Breaking News, Trials & Filings

Trials & Filings in Brief: Dec. 12, 2013

Hisamitsu, ImmunoCellular Therapeutics, Kyowa Hakko Kirin, Lupin, Mallinckrodt, Medivir, Naurex, Orexo, Synta

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

Preclinical Naurex demonstrates mechanism of rapid antidepressant . . . read more Phase II ImmunoCellular misses endpoint in GBM . . . read more Medivir begins combo trial against HCV . . . read more Synta posts interim results in breast cancer . . . read more Phase III Celator DSMB clears AML trial . . . read more Mallinckrodt meets endpoint with pain XR trial . . . read more Launches Lupin launches generic Cymbalta . . . read more Orexo partner launches Abstral in Japan . . . read more...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters